News from aragon pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 04, 2012, 08:00 ET Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers

 Aragon Pharmaceuticals Inc. today announced that the company has raised $50 million in a Series D financing to advance the company's pipeline...


Oct 01, 2012, 08:00 ET Aragon Pharmaceuticals Announces Clinical Results from Ongoing Phase II Trial Confirming Robust Anti-Tumor Activity and Tolerability of ARN-509 in Three Different Patient Populations of Castration Resistant Prostate Cancer

Aragon Pharmaceuticals Inc., a leader in developing drugs for hormone driven cancers, announced new data from an ongoing, open-label, multicenter...


Aug 28, 2012, 08:00 ET Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director

Aragon Pharmaceuticals today announced the appointment of Faheem Hasnain as an independent director of the Company's board of directors. Mr....


Mar 06, 2012, 07:00 ET Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers

 Aragon Pharmaceuticals today announced that the company has secured $42 million in an oversubscribed Series C financing to advance Aragon's...


Aug 09, 2010, 08:00 ET Aragon Pharmaceuticals Doses First Patient in Phase 1/2 Clinical Trial of ARN-509 for Castration-Resistant Prostate Cancer

Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in...


Aug 02, 2010, 08:00 ET Aragon Pharmaceuticals Appoints Richard A. Heyman CEO

Aragon Pharmaceuticals today announced the appointment of company co-founder Richard A. Heyman, Ph.D., to the role of Chief Executive Officer....


Apr 22, 2010, 08:00 ET Aragon Pharmaceuticals Secures $22 Million in Series B Financing

Aragon Pharmaceuticals Inc. today announced that it has secured $22 million in Series B financing. New investor Aisling Capital participated in...


May 20, 2009, 10:30 ET Aragon Pharmaceuticals Announces $8 Million Series A Financing

Aragon Pharmaceuticals today announced it has raised $8 million in Series A financing led by The Column Group and OrbiMed Advisors. Funds from the...